JP2025501746A5 - - Google Patents
Info
- Publication number
- JP2025501746A5 JP2025501746A5 JP2024537865A JP2024537865A JP2025501746A5 JP 2025501746 A5 JP2025501746 A5 JP 2025501746A5 JP 2024537865 A JP2024537865 A JP 2024537865A JP 2024537865 A JP2024537865 A JP 2024537865A JP 2025501746 A5 JP2025501746 A5 JP 2025501746A5
- Authority
- JP
- Japan
- Prior art keywords
- fragment
- pharmaceutical product
- product according
- aat
- inhalation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21216836 | 2021-12-22 | ||
| EP21216836.3 | 2021-12-22 | ||
| EP22166483.2 | 2022-04-04 | ||
| EP22166483 | 2022-04-04 | ||
| PCT/EP2022/087461 WO2023118424A1 (en) | 2021-12-22 | 2022-12-22 | Alpha-1 antitrypsin produced from yeast for use in the treatment of viral infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501746A JP2025501746A (ja) | 2025-01-23 |
| JP2025501746A5 true JP2025501746A5 (enExample) | 2025-12-08 |
Family
ID=84980906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024537865A Pending JP2025501746A (ja) | 2021-12-22 | 2022-12-22 | ウイルス感染症の治療における使用のための酵母から産生されたアルファ－１アンチトリプシン |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250057927A1 (enExample) |
| EP (1) | EP4453233A1 (enExample) |
| JP (1) | JP2025501746A (enExample) |
| AU (1) | AU2022422304A1 (enExample) |
| CA (1) | CA3241852A1 (enExample) |
| IL (1) | IL313247A (enExample) |
| TW (1) | TW202334430A (enExample) |
| WO (1) | WO2023118424A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4731251A1 (en) * | 2023-06-22 | 2026-04-29 | AATEC Medical GmbH | Recombinant aat from yeast to treat bacterial respiratory infections |
| EP4730999A1 (en) * | 2023-06-22 | 2026-04-29 | AATEC Medical GmbH | Recombinant aat from yeast to treat transplants |
| EP4480960A1 (en) * | 2023-06-22 | 2024-12-25 | AATEC Medical GmbH | A recombinant human alpha-1 antitrypsin glycoprotein |
| JP2026525823A (ja) * | 2023-06-22 | 2026-08-04 | エイエイテック メディカル ゲーエムベーハー | 組換えヒトアルファ－１アンチトリプシン糖タンパク質 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4713249A (en) | 1981-11-12 | 1987-12-15 | Schroeder Ulf | Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof |
| US5266333A (en) | 1985-03-06 | 1993-11-30 | American Cyanamid Company | Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone |
| US5417982A (en) | 1994-02-17 | 1995-05-23 | Modi; Pankaj | Controlled release of drugs or hormones in biodegradable polymer microspheres |
| WO2021191900A1 (en) | 2020-03-26 | 2021-09-30 | Kamada Ltd. | Methods for treating infectious diseases caused by coronavirus |
-
2022
- 2022-12-22 EP EP22843749.7A patent/EP4453233A1/en active Pending
- 2022-12-22 TW TW111149485A patent/TW202334430A/zh unknown
- 2022-12-22 IL IL313247A patent/IL313247A/en unknown
- 2022-12-22 WO PCT/EP2022/087461 patent/WO2023118424A1/en not_active Ceased
- 2022-12-22 JP JP2024537865A patent/JP2025501746A/ja active Pending
- 2022-12-22 CA CA3241852A patent/CA3241852A1/en active Pending
- 2022-12-22 AU AU2022422304A patent/AU2022422304A1/en active Pending
- 2022-12-22 US US18/723,224 patent/US20250057927A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Blok et al. | Variation in the membrane-insertion and" stalk" sequences in eight subtypes of influenza type A virus neuraminidase | |
| JP4110329B2 (ja) | ウィルスのエアロゾールの調製方法 | |
| JP2008522617A5 (enExample) | ||
| JPS60226821A (ja) | 化学修飾リンホカインおよびその製造法 | |
| US20250057927A1 (en) | Alpha-1 antitrypsin produced from yeast for use in the treatment of viral infections | |
| US20190292231A1 (en) | Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom | |
| JPH0648956A (ja) | ヒト免疫不全ウィルス感染・増殖抑制剤 | |
| CN114533706B (zh) | 一种用于防治呼吸道疾病的雾化吸入制剂及其应用 | |
| JPH031320B2 (enExample) | ||
| US20130064792A1 (en) | Therapy for influenza like illness | |
| CN109467597B (zh) | 一种新型干扰素及其制备方法、组合物和用途 | |
| EP2647645A1 (en) | Recombinant proteins of Parapoxvirus ovis and pharmaceutical compositions therefrom | |
| JPH029600B2 (enExample) | ||
| EP4480960A1 (en) | A recombinant human alpha-1 antitrypsin glycoprotein | |
| CN118434880A (zh) | 由酵母生产的α-1抗胰蛋白酶用于治疗病毒感染的用途 | |
| EP4480493A1 (en) | A recombinant human alpha-1 antitrypsin glycoprotein for treating non-viral inflammatory diseases of the lung | |
| US20250027067A1 (en) | Improved ace2 fusion proteins | |
| WO2004096852A1 (fr) | Interferon$g(v) humain recombinant, son procede d'expression et ses utilisations | |
| JP2023553117A5 (enExample) | ||
| SU1551251A3 (ru) | Способ получени W-интерферона человека | |
| RU2294372C1 (ru) | СПОСОБ ПОЛУЧЕНИЯ РЕКОМБИНАНТНОГО ИНТЕРФЕРОНА АЛЬФА-2b И ИНТЕРФЕРОНСОДЕРЖАЩИЙ ПРЕПАРАТ (ВАРИАНТЫ) | |
| WO2023081660A1 (en) | Das181 variant compositions | |
| KR20260030111A (ko) | 재조합 인간 알파-1 항트립신 당단백질 | |
| JPH05178756A (ja) | 肝疾患の予防・治療薬 | |
| CN118064410A (zh) | 一种抗病毒蛋白酶cpavm1及其应用 |